Updated Progression-Free Survival and Final Overall Survival with Maintenance Olaparib Plus Bevacizumab According to Clinical Risk in Patients with Newly Diagnosed Advanced Ovarian Cancer in the Phase III PAOLA-1/ENGOT-ov25 TrialDomenica Lorusso,Marie-Ange Mouret-Reynier,Philipp Harter,Claire Cropet,Cristina Caballero,Pia Wolfrum-Ristau,Toyomi Satoh,Ignace Vergote,Gabriella Parma,Trine J. Nottrup,Coriolan Lebreton,Peter A. Fasching,Carmela Pisano,Luis Manso,Hugues Bourgeois,Ingo Runnebaum,Claudio Zamagni,Anne-Claire Hardy-Bessard,Andreas Schnelzer,Michel Fabbro,Barbara Schmalfeldt,Dominique Berton,Antje Belau,Jean-Pierre Lotz,Martina Gropp-Meier,Laurence Gladieff,Hans-Joachim Lueck,Sophie Abadie-Lacourtoisie,Eric Pujade-Lauraine,Isabelle Ray-CoquardINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER（2024）引用 0|浏览25暂无评分关键词Ovarian CancerAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
